Literature DB >> 15963397

Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?

Daniel R Witte1, Jan Westerink, Eelco J de Koning, Yolanda van der Graaf, Diederick E Grobbee, Michiel L Bots.   

Abstract

OBJECTIVES: The aim of this research was to study whether the relation between endothelial function measured by flow-mediated dilation (FMD) of the brachial artery and cardiovascular risk factors is affected by the baseline cardiovascular risk.
BACKGROUND: Flow-mediated dilation of the brachial artery is widely used as a measure of endothelial function. Relations between FMD and most cardiovascular risk factors have been described.
METHODS: We performed a meta-regression analysis of 211 selected articles (399 populations) reporting on FMD and cardiovascular risk factors. Mean values of FMD; age; proportion of men; proportion of smokers; blood pressure; lipids; glucose; and the presence of diabetes mellitus, of hyperlipidemia, and of hypertension were retrieved from the articles. The 10-year risk of coronary heart disease (CHD) for each population was estimated based on the Framingham risk score. The relation between FMD and cardiovascular risk factors was assessed within each risk category by linear regression analysis, adjusting for age and gender, and weighted for the study size.
RESULTS: A relation between FMD and cardiovascular risk factors was most clear in the category with lowest baseline risk (below 2.8% per decade). In populations with low baseline risk, for each % increase in Framingham risk, FMD decreased by 1.42% (95% confidence interval: 0.65 to 2.19). In medium- and high-risk populations, FMD was not related to risk (-0.02% [-0.27 to 0.22] and 0.06% [-0.02 to 0.13], respectively). These findings were independent of differences in brachial lumen diameter and technical aspects of the FMD measurement.
CONCLUSIONS: Only in populations at low risk, endothelial function measured by FMD is related to the principal cardiovascular risk factors, and to the estimated 10-year risk of CHD.

Entities:  

Mesh:

Year:  2005        PMID: 15963397     DOI: 10.1016/j.jacc.2005.02.073

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  46 in total

1.  Effects of various doses of aspirin on platelet activity and endothelial function.

Authors:  Takashi Furuno; Fumiyasu Yamasaki; Takeshi Yokoyama; Kyoko Sato; Takayuki Sato; Yoshinori Doi; Tetsuro Sugiura
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 2.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

Review 3.  The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.

Authors:  Kyra E Pyke; Michael E Tschakovsky
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

4.  Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.

Authors:  Joseph Yeboah; Aaron R Folsom; Gregory L Burke; Craig Johnson; Joseph F Polak; Wendy Post; Joao A Lima; John R Crouse; David M Herrington
Journal:  Circulation       Date:  2009-07-27       Impact factor: 29.690

Review 5.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 6.  Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A review.

Authors:  Kayla R Zehr; Mary K Walker
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-08-09       Impact factor: 3.072

Review 7.  Imaging subclinical atherosclerosis: is it ready for prime time? A review.

Authors:  Leticia Fernández-Friera; Borja Ibáñez; Valentín Fuster
Journal:  J Cardiovasc Transl Res       Date:  2014-08-14       Impact factor: 4.132

8.  Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.

Authors:  Stefano Rizza; Ranganath Muniyappa; Micaela Iantorno; Jeong-a Kim; Hui Chen; Philomena Pullikotil; Nicoletta Senese; Manfredi Tesauro; Davide Lauro; Carmine Cardillo; Michael J Quon
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

9.  Measurement of brachial artery endothelial function using a standard blood pressure cuff.

Authors:  Jonathan S Maltz; Geoffrey H Tison; Hugh F Alley; Thomas F Budinger; Christopher D Owens; Jeffrey Olgin
Journal:  Physiol Meas       Date:  2015-09-22       Impact factor: 2.833

10.  Brachial artery vasoreactivity is associated with cross-sectional and longitudinal anatomical measures of atherosclerosis in postmenopausal women with coronary artery disease.

Authors:  Nicole M Gatto; Howard N Hodis; Chao-Ran Liu; Chi-Hua Liu; Wendy J Mack
Journal:  Atherosclerosis       Date:  2007-09-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.